Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT06852573
What this trial is testing

Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Beijing Immunochina Medical Science & Technology Co., Ltd. 18
Not applicableStudy completedNCT04522505
What this trial is testing

Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis

Who this might be right for
Lupus Nephritis
Corestemchemon, Inc. 6
Not applicableLooking for participantsNCT07517250
What this trial is testing

A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients

Who this might be right for
Familial Mediterranean FeverStill DiseaseSystemic Juvenile Idiopathic Arthritis+1 more
Novartis Pharmaceuticals 160
Testing effectiveness (Phase 2)Study completedNCT05162586
What this trial is testing

The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

Who this might be right for
Systemic Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 456
Testing effectiveness (Phase 2)Study completedNCT00981708
What this trial is testing

Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)

Who this might be right for
Amyloidosis
University of Athens 37
Not applicableLooking for participantsNCT06462768
What this trial is testing

Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis

Who this might be right for
Systemic SclerosisOther Connective Tissue DiseaseSystemic Lupus Erythematosus+2 more
CHU de Reims 260
Not applicableUnknownNCT06255743
What this trial is testing

(Anti-Ribosomal P Protein,Anti-U1 RNP, Anti-Nucleosome and Anti-ds DNA Antibodies) and Relation to Depression and Anxiety in SLE

Who this might be right for
Systemic Lupus Erythematosus
Sohag University 50
Testing effectiveness (Phase 2)WithdrawnNCT00390091
What this trial is testing

Study of LJP 394 (Abetimus Sodium) in Lupus Patients

Who this might be right for
Systemic Lupus Erythematosus
La Jolla Pharmaceutical Company
Not applicableStudy completedNCT02281513
What this trial is testing

Activity and Nutrition Trial in Lupus to Energize and Renew

Who this might be right for
Systemic Lupus ErythematosusPhysical ActivitySleep
Northwestern University 12
Not applicableUnknownNCT03804723
What this trial is testing

Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusGlucocorticoidsTherapy Withdrawal
University of Pisa 321
Testing effectiveness (Phase 2)Looking for participantsNCT05475925
What this trial is testing

DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Who this might be right for
LGLL - Large Granular Lymphocytic LeukemiaPrimary Cutaneous Gamma-Delta T-Cell LymphomaPrimary Cutaneous CD8+ Aggressive Epidermotropic T-Cell Lymphoma+10 more
Dren Bio 200
Large-scale testing (Phase 3)UnknownNCT00053560
What this trial is testing

To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

Who this might be right for
Lupus
Genelabs Technologies 155
Testing effectiveness (Phase 2)Study completedNCT02437890
What this trial is testing

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Ablynx, a Sanofi company 312
Not applicableStudy completedNCT02510092
What this trial is testing

Coronary Artery and Systemic Autoimmune Disease: Diagnostics and Treatment

Who this might be right for
Autoimmune DiseasesCoronary Artery Disease
Semmelweis University Heart and Vascular Center 11
Not applicableStudy completedNCT04895878
What this trial is testing

Patients With Co-occurrence of ANCA Vasculitis and Sjögren Syndrome

Who this might be right for
ANCA Associated VasculitisSjogren's Syndrome
University Hospital, Montpellier 5
Not applicableStudy completedNCT03923920
What this trial is testing

Screening for Systemic Amyloidosis Via the Ligamentum Flavum

Who this might be right for
AmyloidAmyloidosisSpinal Stenosis+2 more
The Cleveland Clinic 200
Testing effectiveness (Phase 2)Looking for participantsNCT07348055
What this trial is testing

GR1803 in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErthematosusAuto Immune Disease
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 44
Testing effectiveness (Phase 2)Study completedNCT00054938
What this trial is testing

Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus
Brigham and Women's Hospital 150
Large-scale testing (Phase 3)Ended earlyNCT00539838
What this trial is testing

Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)

Who this might be right for
Systemic Lupus Erythematosus
Genentech, Inc. 33
Not applicableUnknownNCT01095146
What this trial is testing

New Candidate Criteria for Diagnosis of Macrophage Activation Syndrome

Who this might be right for
Macrophage Activation SyndromeLymphohistiocytosis, Hemophagocytic
Amrita Institute of Medical Sciences & Research Center 50
Next Page